Avanir

pulls plug pulling plug
Pharma

Otsuka gives up on Alzheimer's drug after 2nd failed trial

Otsuka is packing up an Alzheimer’s disease med after a phase 3 study failed to move the needle on measures of agitation associated with dementia.
Asia map globe

Eisai, GSK, Daiichi Sankyo—Fierce Pharma Asia

Nov 4, 2022 9:00am
Asia Map

Astellas, Takeda, Lilly-Innovent and more—FiercePharmaAsia

Jan 17, 2020 8:40am
California

Otsuka's Avanir unit plots 140 layoffs after Nuedexta settlement

Jan 10, 2020 11:35am
Asia Map

Otsuka, China's bidding, Aurobindo and more—FiercePharmaAsia

Sep 27, 2019 10:10am
lady justice statue

Avanir agrees to pay $116M over Nuedexta kickbacks probe

Sep 26, 2019 3:55pm